NCT04800822 2024-10-22PF-07284892 in Participants With Advanced Solid TumorsPfizerPhase 1 Terminated53 enrolled
NCT04390243 2024-05-06Binimetinib and Encorafenib for the Treatment of Pancreatic Cancer in Patients With a Somatic BRAF V600E MutationAcademic and Community Cancer Research UnitedPhase 2 Terminated6 enrolled 16 charts